Competent Cells Market - Global Outlook and Forecast 2021-2027
![](/report_cover/11201/competent-cells-market-global-outlook-n-forecast-2021-2027_en.gif)
This report contains market size and forecasts of Competent Cells in Global, including the following market information:
Global Competent Cells Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Competent Cells market was valued at 1886.6 million in 2020 and is projected to reach US$ 2672 million by 2027, at a CAGR of 9.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Competent Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Competent Cells Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Competent Cells Market Segment Percentages, By Type, 2020 (%)
China Competent Cells Market Segment Percentages, By Application, 2020 (%)
Global Competent Cells Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Total Competent Cells Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Competent Cells Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Global Competent Cells Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Competent Cells market was valued at 1886.6 million in 2020 and is projected to reach US$ 2672 million by 2027, at a CAGR of 9.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Competent Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Competent Cells Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Competent Cells Market Segment Percentages, By Type, 2020 (%)
- Chemically Competent Cells
- Electrocompetent Cells
China Competent Cells Market Segment Percentages, By Application, 2020 (%)
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
Global Competent Cells Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Total Competent Cells Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Competent Cells Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Competent Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Competent Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL COMPETENT CELLS OVERALL MARKET SIZE
2.1 Global Competent Cells Market Size: 2021 VS 2027
2.2 Global Competent Cells Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Competent Cells Players in Global Market
3.2 Top Global Competent Cells Companies Ranked by Revenue
3.3 Global Competent Cells Revenue by Companies
3.4 Top 3 and Top 5 Competent Cells Companies in Global Market, by Revenue in 2020
3.5 Global Companies Competent Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Competent Cells Players in Global Market
3.6.1 List of Global Tier 1 Competent Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Competent Cells Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Competent Cells Market Size Markets, 2021 & 2027
4.1.2 Chemically Competent Cells
4.1.3 Electrocompetent Cells
4.2 By Type - Global Competent Cells Revenue & Forecasts
4.2.1 By Type - Global Competent Cells Revenue, 2016-2021
4.2.2 By Type - Global Competent Cells Revenue, 2022-2027
4.2.3 By Type - Global Competent Cells Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Competent Cells Market Size, 2021 & 2027
5.1.2 Subcloning & Routine Cloning
5.1.3 Phage Display Library Construction
5.1.4 Toxic/Unstable DNA Cloning
5.1.5 High-Throughput Cloning
5.1.6 Protein Expression
5.1.7 Mutagenesis
5.1.8 Single-Stranded DNA Production
5.1.9 Bacmid Creation
5.1.10 Cre-Lox Recombination (PIR1/PIR2)
5.2 By Application - Global Competent Cells Revenue & Forecasts
5.2.1 By Application - Global Competent Cells Revenue, 2016-2021
5.2.2 By Application - Global Competent Cells Revenue, 2022-2027
5.2.3 By Application - Global Competent Cells Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Competent Cells Market Size, 2021 & 2027
6.2 By Region - Global Competent Cells Revenue & Forecasts
6.2.1 By Region - Global Competent Cells Revenue, 2016-2021
6.2.2 By Region - Global Competent Cells Revenue, 2022-2027
6.2.3 By Region - Global Competent Cells Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Competent Cells Revenue, 2016-2027
6.3.2 US Competent Cells Market Size, 2016-2027
6.3.3 Canada Competent Cells Market Size, 2016-2027
6.3.4 Mexico Competent Cells Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Competent Cells Revenue, 2016-2027
6.4.2 Germany Competent Cells Market Size, 2016-2027
6.4.3 France Competent Cells Market Size, 2016-2027
6.4.4 U.K. Competent Cells Market Size, 2016-2027
6.4.5 Italy Competent Cells Market Size, 2016-2027
6.4.6 Russia Competent Cells Market Size, 2016-2027
6.4.7 Nordic Countries Competent Cells Market Size, 2016-2027
6.4.8 Benelux Competent Cells Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Competent Cells Revenue, 2016-2027
6.5.2 China Competent Cells Market Size, 2016-2027
6.5.3 Japan Competent Cells Market Size, 2016-2027
6.5.4 South Korea Competent Cells Market Size, 2016-2027
6.5.5 Southeast Asia Competent Cells Market Size, 2016-2027
6.5.6 India Competent Cells Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Competent Cells Revenue, 2016-2027
6.6.2 Brazil Competent Cells Market Size, 2016-2027
6.6.3 Argentina Competent Cells Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Competent Cells Revenue, 2016-2027
6.7.2 Turkey Competent Cells Market Size, 2016-2027
6.7.3 Israel Competent Cells Market Size, 2016-2027
6.7.4 Saudi Arabia Competent Cells Market Size, 2016-2027
6.7.5 UAE Competent Cells Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Merck KGaA
7.1.1 Merck KGaA Corporate Summary
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Competent Cells Major Product Offerings
7.1.4 Merck KGaA Competent Cells Revenue in Global (2016-2021)
7.1.5 Merck KGaA Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Competent Cells Major Product Offerings
7.2.4 Thermo Fisher Scientific Competent Cells Revenue in Global (2016-2021)
7.2.5 Thermo Fisher Scientific Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Competent Cells Major Product Offerings
7.3.4 Agilent Technologies Competent Cells Revenue in Global (2016-2021)
7.3.5 Agilent Technologies Key News
7.4 Takara Bio
7.4.1 Takara Bio Corporate Summary
7.4.2 Takara Bio Business Overview
7.4.3 Takara Bio Competent Cells Major Product Offerings
7.4.4 Takara Bio Competent Cells Revenue in Global (2016-2021)
7.4.5 Takara Bio Key News
7.5 Promega Corporation
7.5.1 Promega Corporation Corporate Summary
7.5.2 Promega Corporation Business Overview
7.5.3 Promega Corporation Competent Cells Major Product Offerings
7.5.4 Promega Corporation Competent Cells Revenue in Global (2016-2021)
7.5.5 Promega Corporation Key News
7.6 Beijing TransGen Biotech
7.6.1 Beijing TransGen Biotech Corporate Summary
7.6.2 Beijing TransGen Biotech Business Overview
7.6.3 Beijing TransGen Biotech Competent Cells Major Product Offerings
7.6.4 Beijing TransGen Biotech Competent Cells Revenue in Global (2016-2021)
7.6.5 Beijing TransGen Biotech Key News
7.7 GeneScript Corporation
7.7.1 GeneScript Corporation Corporate Summary
7.7.2 GeneScript Corporation Business Overview
7.7.3 GeneScript Corporation Competent Cells Major Product Offerings
7.4.4 GeneScript Corporation Competent Cells Revenue in Global (2016-2021)
7.7.5 GeneScript Corporation Key News
7.8 Yeastern Biotech
7.8.1 Yeastern Biotech Corporate Summary
7.8.2 Yeastern Biotech Business Overview
7.8.3 Yeastern Biotech Competent Cells Major Product Offerings
7.8.4 Yeastern Biotech Competent Cells Revenue in Global (2016-2021)
7.8.5 Yeastern Biotech Key News
7.9 New England Biolabs
7.9.1 New England Biolabs Corporate Summary
7.9.2 New England Biolabs Business Overview
7.9.3 New England Biolabs Competent Cells Major Product Offerings
7.9.4 New England Biolabs Competent Cells Revenue in Global (2016-2021)
7.9.5 New England Biolabs Key News
7.10 QIAGEN N.V.
7.10.1 QIAGEN N.V. Corporate Summary
7.10.2 QIAGEN N.V. Business Overview
7.10.3 QIAGEN N.V. Competent Cells Major Product Offerings
7.10.4 QIAGEN N.V. Competent Cells Revenue in Global (2016-2021)
7.10.5 QIAGEN N.V. Key News
7.11 OriGene Technologies
7.11.1 OriGene Technologies Corporate Summary
7.11.2 OriGene Technologies Business Overview
7.11.3 OriGene Technologies Competent Cells Major Product Offerings
7.11.4 OriGene Technologies Competent Cells Revenue in Global (2016-2021)
7.11.5 OriGene Technologies Key News
7.12 Lucigen
7.12.1 Lucigen Corporate Summary
7.12.2 Lucigen Business Overview
7.12.3 Lucigen Competent Cells Major Product Offerings
7.12.4 Lucigen Competent Cells Revenue in Global (2016-2021)
7.12.5 Lucigen Key News
7.13 Zymo Research
7.13.1 Zymo Research Corporate Summary
7.13.2 Zymo Research Business Overview
7.13.3 Zymo Research Competent Cells Major Product Offerings
7.13.4 Zymo Research Competent Cells Revenue in Global (2016-2021)
7.13.5 Zymo Research Key News
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Corporate Summary
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Competent Cells Major Product Offerings
7.14.4 Bio-Rad Laboratories Competent Cells Revenue in Global (2016-2021)
7.14.5 Bio-Rad Laboratories Key News
7.15 Bioline
7.15.1 Bioline Corporate Summary
7.15.2 Bioline Business Overview
7.15.3 Bioline Competent Cells Major Product Offerings
7.15.4 Bioline Competent Cells Revenue in Global (2016-2021)
7.15.5 Bioline Key News
7.16 Delphi Genetics
7.16.1 Delphi Genetics Corporate Summary
7.16.2 Delphi Genetics Business Overview
7.16.3 Delphi Genetics Competent Cells Major Product Offerings
7.16.4 Delphi Genetics Competent Cells Revenue in Global (2016-2021)
7.16.5 Delphi Genetics Key News
7.17 IBA GmBH
7.17.1 IBA GmBH Corporate Summary
7.17.2 IBA GmBH Business Overview
7.17.3 IBA GmBH Competent Cells Major Product Offerings
7.17.4 IBA GmBH Competent Cells Revenue in Global (2016-2021)
7.17.5 IBA GmBH Key News
7.18 Cell Applications
7.18.1 Cell Applications Corporate Summary
7.18.2 Cell Applications Business Overview
7.18.3 Cell Applications Competent Cells Major Product Offerings
7.18.4 Cell Applications Competent Cells Revenue in Global (2016-2021)
7.18.5 Cell Applications Key News
7.19 BioDynamics Laboratory
7.19.1 BioDynamics Laboratory Corporate Summary
7.19.2 BioDynamics Laboratory Business Overview
7.19.3 BioDynamics Laboratory Competent Cells Major Product Offerings
7.19.4 BioDynamics Laboratory Competent Cells Revenue in Global (2016-2021)
7.19.5 BioDynamics Laboratory Key News
7.20 Scarab Genomics
7.20.1 Scarab Genomics Corporate Summary
7.20.2 Scarab Genomics Business Overview
7.20.3 Scarab Genomics Competent Cells Major Product Offerings
7.20.4 Scarab Genomics Competent Cells Revenue in Global (2016-2021)
7.20.5 Scarab Genomics Key News
7.21 GCC Biotech
7.21.1 GCC Biotech Corporate Summary
7.21.2 GCC Biotech Business Overview
7.21.3 GCC Biotech Competent Cells Major Product Offerings
7.21.4 GCC Biotech Competent Cells Revenue in Global (2016-2021)
7.21.5 GCC Biotech Key News
7.22 SMOBIO Technology
7.22.1 SMOBIO Technology Corporate Summary
7.22.2 SMOBIO Technology Business Overview
7.22.3 SMOBIO Technology Competent Cells Major Product Offerings
7.22.4 SMOBIO Technology Competent Cells Revenue in Global (2016-2021)
7.22.5 SMOBIO Technology Key News
7.23 Edge BioSystems
7.23.1 Edge BioSystems Corporate Summary
7.23.2 Edge BioSystems Business Overview
7.23.3 Edge BioSystems Competent Cells Major Product Offerings
7.23.4 Edge BioSystems Competent Cells Revenue in Global (2016-2021)
7.23.5 Edge BioSystems Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Competent Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Competent Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL COMPETENT CELLS OVERALL MARKET SIZE
2.1 Global Competent Cells Market Size: 2021 VS 2027
2.2 Global Competent Cells Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Competent Cells Players in Global Market
3.2 Top Global Competent Cells Companies Ranked by Revenue
3.3 Global Competent Cells Revenue by Companies
3.4 Top 3 and Top 5 Competent Cells Companies in Global Market, by Revenue in 2020
3.5 Global Companies Competent Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Competent Cells Players in Global Market
3.6.1 List of Global Tier 1 Competent Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Competent Cells Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Competent Cells Market Size Markets, 2021 & 2027
4.1.2 Chemically Competent Cells
4.1.3 Electrocompetent Cells
4.2 By Type - Global Competent Cells Revenue & Forecasts
4.2.1 By Type - Global Competent Cells Revenue, 2016-2021
4.2.2 By Type - Global Competent Cells Revenue, 2022-2027
4.2.3 By Type - Global Competent Cells Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Competent Cells Market Size, 2021 & 2027
5.1.2 Subcloning & Routine Cloning
5.1.3 Phage Display Library Construction
5.1.4 Toxic/Unstable DNA Cloning
5.1.5 High-Throughput Cloning
5.1.6 Protein Expression
5.1.7 Mutagenesis
5.1.8 Single-Stranded DNA Production
5.1.9 Bacmid Creation
5.1.10 Cre-Lox Recombination (PIR1/PIR2)
5.2 By Application - Global Competent Cells Revenue & Forecasts
5.2.1 By Application - Global Competent Cells Revenue, 2016-2021
5.2.2 By Application - Global Competent Cells Revenue, 2022-2027
5.2.3 By Application - Global Competent Cells Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Competent Cells Market Size, 2021 & 2027
6.2 By Region - Global Competent Cells Revenue & Forecasts
6.2.1 By Region - Global Competent Cells Revenue, 2016-2021
6.2.2 By Region - Global Competent Cells Revenue, 2022-2027
6.2.3 By Region - Global Competent Cells Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Competent Cells Revenue, 2016-2027
6.3.2 US Competent Cells Market Size, 2016-2027
6.3.3 Canada Competent Cells Market Size, 2016-2027
6.3.4 Mexico Competent Cells Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Competent Cells Revenue, 2016-2027
6.4.2 Germany Competent Cells Market Size, 2016-2027
6.4.3 France Competent Cells Market Size, 2016-2027
6.4.4 U.K. Competent Cells Market Size, 2016-2027
6.4.5 Italy Competent Cells Market Size, 2016-2027
6.4.6 Russia Competent Cells Market Size, 2016-2027
6.4.7 Nordic Countries Competent Cells Market Size, 2016-2027
6.4.8 Benelux Competent Cells Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Competent Cells Revenue, 2016-2027
6.5.2 China Competent Cells Market Size, 2016-2027
6.5.3 Japan Competent Cells Market Size, 2016-2027
6.5.4 South Korea Competent Cells Market Size, 2016-2027
6.5.5 Southeast Asia Competent Cells Market Size, 2016-2027
6.5.6 India Competent Cells Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Competent Cells Revenue, 2016-2027
6.6.2 Brazil Competent Cells Market Size, 2016-2027
6.6.3 Argentina Competent Cells Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Competent Cells Revenue, 2016-2027
6.7.2 Turkey Competent Cells Market Size, 2016-2027
6.7.3 Israel Competent Cells Market Size, 2016-2027
6.7.4 Saudi Arabia Competent Cells Market Size, 2016-2027
6.7.5 UAE Competent Cells Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 Merck KGaA
7.1.1 Merck KGaA Corporate Summary
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Competent Cells Major Product Offerings
7.1.4 Merck KGaA Competent Cells Revenue in Global (2016-2021)
7.1.5 Merck KGaA Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Competent Cells Major Product Offerings
7.2.4 Thermo Fisher Scientific Competent Cells Revenue in Global (2016-2021)
7.2.5 Thermo Fisher Scientific Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Competent Cells Major Product Offerings
7.3.4 Agilent Technologies Competent Cells Revenue in Global (2016-2021)
7.3.5 Agilent Technologies Key News
7.4 Takara Bio
7.4.1 Takara Bio Corporate Summary
7.4.2 Takara Bio Business Overview
7.4.3 Takara Bio Competent Cells Major Product Offerings
7.4.4 Takara Bio Competent Cells Revenue in Global (2016-2021)
7.4.5 Takara Bio Key News
7.5 Promega Corporation
7.5.1 Promega Corporation Corporate Summary
7.5.2 Promega Corporation Business Overview
7.5.3 Promega Corporation Competent Cells Major Product Offerings
7.5.4 Promega Corporation Competent Cells Revenue in Global (2016-2021)
7.5.5 Promega Corporation Key News
7.6 Beijing TransGen Biotech
7.6.1 Beijing TransGen Biotech Corporate Summary
7.6.2 Beijing TransGen Biotech Business Overview
7.6.3 Beijing TransGen Biotech Competent Cells Major Product Offerings
7.6.4 Beijing TransGen Biotech Competent Cells Revenue in Global (2016-2021)
7.6.5 Beijing TransGen Biotech Key News
7.7 GeneScript Corporation
7.7.1 GeneScript Corporation Corporate Summary
7.7.2 GeneScript Corporation Business Overview
7.7.3 GeneScript Corporation Competent Cells Major Product Offerings
7.4.4 GeneScript Corporation Competent Cells Revenue in Global (2016-2021)
7.7.5 GeneScript Corporation Key News
7.8 Yeastern Biotech
7.8.1 Yeastern Biotech Corporate Summary
7.8.2 Yeastern Biotech Business Overview
7.8.3 Yeastern Biotech Competent Cells Major Product Offerings
7.8.4 Yeastern Biotech Competent Cells Revenue in Global (2016-2021)
7.8.5 Yeastern Biotech Key News
7.9 New England Biolabs
7.9.1 New England Biolabs Corporate Summary
7.9.2 New England Biolabs Business Overview
7.9.3 New England Biolabs Competent Cells Major Product Offerings
7.9.4 New England Biolabs Competent Cells Revenue in Global (2016-2021)
7.9.5 New England Biolabs Key News
7.10 QIAGEN N.V.
7.10.1 QIAGEN N.V. Corporate Summary
7.10.2 QIAGEN N.V. Business Overview
7.10.3 QIAGEN N.V. Competent Cells Major Product Offerings
7.10.4 QIAGEN N.V. Competent Cells Revenue in Global (2016-2021)
7.10.5 QIAGEN N.V. Key News
7.11 OriGene Technologies
7.11.1 OriGene Technologies Corporate Summary
7.11.2 OriGene Technologies Business Overview
7.11.3 OriGene Technologies Competent Cells Major Product Offerings
7.11.4 OriGene Technologies Competent Cells Revenue in Global (2016-2021)
7.11.5 OriGene Technologies Key News
7.12 Lucigen
7.12.1 Lucigen Corporate Summary
7.12.2 Lucigen Business Overview
7.12.3 Lucigen Competent Cells Major Product Offerings
7.12.4 Lucigen Competent Cells Revenue in Global (2016-2021)
7.12.5 Lucigen Key News
7.13 Zymo Research
7.13.1 Zymo Research Corporate Summary
7.13.2 Zymo Research Business Overview
7.13.3 Zymo Research Competent Cells Major Product Offerings
7.13.4 Zymo Research Competent Cells Revenue in Global (2016-2021)
7.13.5 Zymo Research Key News
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Corporate Summary
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Competent Cells Major Product Offerings
7.14.4 Bio-Rad Laboratories Competent Cells Revenue in Global (2016-2021)
7.14.5 Bio-Rad Laboratories Key News
7.15 Bioline
7.15.1 Bioline Corporate Summary
7.15.2 Bioline Business Overview
7.15.3 Bioline Competent Cells Major Product Offerings
7.15.4 Bioline Competent Cells Revenue in Global (2016-2021)
7.15.5 Bioline Key News
7.16 Delphi Genetics
7.16.1 Delphi Genetics Corporate Summary
7.16.2 Delphi Genetics Business Overview
7.16.3 Delphi Genetics Competent Cells Major Product Offerings
7.16.4 Delphi Genetics Competent Cells Revenue in Global (2016-2021)
7.16.5 Delphi Genetics Key News
7.17 IBA GmBH
7.17.1 IBA GmBH Corporate Summary
7.17.2 IBA GmBH Business Overview
7.17.3 IBA GmBH Competent Cells Major Product Offerings
7.17.4 IBA GmBH Competent Cells Revenue in Global (2016-2021)
7.17.5 IBA GmBH Key News
7.18 Cell Applications
7.18.1 Cell Applications Corporate Summary
7.18.2 Cell Applications Business Overview
7.18.3 Cell Applications Competent Cells Major Product Offerings
7.18.4 Cell Applications Competent Cells Revenue in Global (2016-2021)
7.18.5 Cell Applications Key News
7.19 BioDynamics Laboratory
7.19.1 BioDynamics Laboratory Corporate Summary
7.19.2 BioDynamics Laboratory Business Overview
7.19.3 BioDynamics Laboratory Competent Cells Major Product Offerings
7.19.4 BioDynamics Laboratory Competent Cells Revenue in Global (2016-2021)
7.19.5 BioDynamics Laboratory Key News
7.20 Scarab Genomics
7.20.1 Scarab Genomics Corporate Summary
7.20.2 Scarab Genomics Business Overview
7.20.3 Scarab Genomics Competent Cells Major Product Offerings
7.20.4 Scarab Genomics Competent Cells Revenue in Global (2016-2021)
7.20.5 Scarab Genomics Key News
7.21 GCC Biotech
7.21.1 GCC Biotech Corporate Summary
7.21.2 GCC Biotech Business Overview
7.21.3 GCC Biotech Competent Cells Major Product Offerings
7.21.4 GCC Biotech Competent Cells Revenue in Global (2016-2021)
7.21.5 GCC Biotech Key News
7.22 SMOBIO Technology
7.22.1 SMOBIO Technology Corporate Summary
7.22.2 SMOBIO Technology Business Overview
7.22.3 SMOBIO Technology Competent Cells Major Product Offerings
7.22.4 SMOBIO Technology Competent Cells Revenue in Global (2016-2021)
7.22.5 SMOBIO Technology Key News
7.23 Edge BioSystems
7.23.1 Edge BioSystems Corporate Summary
7.23.2 Edge BioSystems Business Overview
7.23.3 Edge BioSystems Competent Cells Major Product Offerings
7.23.4 Edge BioSystems Competent Cells Revenue in Global (2016-2021)
7.23.5 Edge BioSystems Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Competent Cells Market Opportunities & Trends in Global Market
Table 2. Competent Cells Market Drivers in Global Market
Table 3. Competent Cells Market Restraints in Global Market
Table 4. Key Players of Competent Cells in Global Market
Table 5. Top Competent Cells Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Competent Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Competent Cells Revenue Share by Companies, 2016-2021
Table 8. Global Companies Competent Cells Product Type
Table 9. List of Global Tier 1 Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Competent Cells Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Competent Cells Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Competent Cells Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Competent Cells Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Competent Cells Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Competent Cells Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Competent Cells Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Competent Cells Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Competent Cells Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Competent Cells Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Competent Cells Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Competent Cells Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Competent Cells Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Competent Cells Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Competent Cells Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Competent Cells Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Competent Cells Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Competent Cells Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Competent Cells Revenue, (US$, Mn), 2022-2027
Table 30. Merck KGaA Corporate Summary
Table 31. Merck KGaA Competent Cells Product Offerings
Table 32. Merck KGaA Competent Cells Revenue (US$, Mn), (2016-2021)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific Competent Cells Product Offerings
Table 35. Thermo Fisher Scientific Competent Cells Revenue (US$, Mn), (2016-2021)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies Competent Cells Product Offerings
Table 38. Agilent Technologies Competent Cells Revenue (US$, Mn), (2016-2021)
Table 39. Takara Bio Corporate Summary
Table 40. Takara Bio Competent Cells Product Offerings
Table 41. Takara Bio Competent Cells Revenue (US$, Mn), (2016-2021)
Table 42. Promega Corporation Corporate Summary
Table 43. Promega Corporation Competent Cells Product Offerings
Table 44. Promega Corporation Competent Cells Revenue (US$, Mn), (2016-2021)
Table 45. Beijing TransGen Biotech Corporate Summary
Table 46. Beijing TransGen Biotech Competent Cells Product Offerings
Table 47. Beijing TransGen Biotech Competent Cells Revenue (US$, Mn), (2016-2021)
Table 48. GeneScript Corporation Corporate Summary
Table 49. GeneScript Corporation Competent Cells Product Offerings
Table 50. GeneScript Corporation Competent Cells Revenue (US$, Mn), (2016-2021)
Table 51. Yeastern Biotech Corporate Summary
Table 52. Yeastern Biotech Competent Cells Product Offerings
Table 53. Yeastern Biotech Competent Cells Revenue (US$, Mn), (2016-2021)
Table 54. New England Biolabs Corporate Summary
Table 55. New England Biolabs Competent Cells Product Offerings
Table 56. New England Biolabs Competent Cells Revenue (US$, Mn), (2016-2021)
Table 57. QIAGEN N.V. Corporate Summary
Table 58. QIAGEN N.V. Competent Cells Product Offerings
Table 59. QIAGEN N.V. Competent Cells Revenue (US$, Mn), (2016-2021)
Table 60. OriGene Technologies Corporate Summary
Table 61. OriGene Technologies Competent Cells Product Offerings
Table 62. OriGene Technologies Competent Cells Revenue (US$, Mn), (2016-2021)
Table 63. Lucigen Corporate Summary
Table 64. Lucigen Competent Cells Product Offerings
Table 65. Lucigen Competent Cells Revenue (US$, Mn), (2016-2021)
Table 66. Zymo Research Corporate Summary
Table 67. Zymo Research Competent Cells Product Offerings
Table 68. Zymo Research Competent Cells Revenue (US$, Mn), (2016-2021)
Table 69. Bio-Rad Laboratories Corporate Summary
Table 70. Bio-Rad Laboratories Competent Cells Product Offerings
Table 71. Bio-Rad Laboratories Competent Cells Revenue (US$, Mn), (2016-2021)
Table 72. Bioline Corporate Summary
Table 73. Bioline Competent Cells Product Offerings
Table 74. Bioline Competent Cells Revenue (US$, Mn), (2016-2021)
Table 75. Delphi Genetics Corporate Summary
Table 76. Delphi Genetics Competent Cells Product Offerings
Table 77. Delphi Genetics Competent Cells Revenue (US$, Mn), (2016-2021)
Table 78. IBA GmBH Corporate Summary
Table 79. IBA GmBH Competent Cells Product Offerings
Table 80. IBA GmBH Competent Cells Revenue (US$, Mn), (2016-2021)
Table 81. Cell Applications Corporate Summary
Table 82. Cell Applications Competent Cells Product Offerings
Table 83. Cell Applications Competent Cells Revenue (US$, Mn), (2016-2021)
Table 84. BioDynamics Laboratory Corporate Summary
Table 85. BioDynamics Laboratory Competent Cells Product Offerings
Table 86. BioDynamics Laboratory Competent Cells Revenue (US$, Mn), (2016-2021)
Table 87. Scarab Genomics Corporate Summary
Table 88. Scarab Genomics Competent Cells Product Offerings
Table 89. Scarab Genomics Competent Cells Revenue (US$, Mn), (2016-2021)
Table 90. GCC Biotech Corporate Summary
Table 91. GCC Biotech Competent Cells Product Offerings
Table 92. GCC Biotech Competent Cells Revenue (US$, Mn), (2016-2021)
Table 93. SMOBIO Technology Corporate Summary
Table 94. SMOBIO Technology Competent Cells Product Offerings
Table 95. SMOBIO Technology Competent Cells Revenue (US$, Mn), (2016-2021)
Table 96. Edge BioSystems Corporate Summary
Table 97. Edge BioSystems Competent Cells Product Offerings
Table 98. Edge BioSystems Competent Cells Revenue (US$, Mn), (2016-2021)
Table 1. Competent Cells Market Opportunities & Trends in Global Market
Table 2. Competent Cells Market Drivers in Global Market
Table 3. Competent Cells Market Restraints in Global Market
Table 4. Key Players of Competent Cells in Global Market
Table 5. Top Competent Cells Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Competent Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Competent Cells Revenue Share by Companies, 2016-2021
Table 8. Global Companies Competent Cells Product Type
Table 9. List of Global Tier 1 Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Competent Cells Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Competent Cells Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Competent Cells Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Competent Cells Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Competent Cells Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Competent Cells Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Competent Cells Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Competent Cells Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Competent Cells Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Competent Cells Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Competent Cells Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Competent Cells Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Competent Cells Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Competent Cells Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Competent Cells Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Competent Cells Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Competent Cells Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Competent Cells Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Competent Cells Revenue, (US$, Mn), 2022-2027
Table 30. Merck KGaA Corporate Summary
Table 31. Merck KGaA Competent Cells Product Offerings
Table 32. Merck KGaA Competent Cells Revenue (US$, Mn), (2016-2021)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific Competent Cells Product Offerings
Table 35. Thermo Fisher Scientific Competent Cells Revenue (US$, Mn), (2016-2021)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies Competent Cells Product Offerings
Table 38. Agilent Technologies Competent Cells Revenue (US$, Mn), (2016-2021)
Table 39. Takara Bio Corporate Summary
Table 40. Takara Bio Competent Cells Product Offerings
Table 41. Takara Bio Competent Cells Revenue (US$, Mn), (2016-2021)
Table 42. Promega Corporation Corporate Summary
Table 43. Promega Corporation Competent Cells Product Offerings
Table 44. Promega Corporation Competent Cells Revenue (US$, Mn), (2016-2021)
Table 45. Beijing TransGen Biotech Corporate Summary
Table 46. Beijing TransGen Biotech Competent Cells Product Offerings
Table 47. Beijing TransGen Biotech Competent Cells Revenue (US$, Mn), (2016-2021)
Table 48. GeneScript Corporation Corporate Summary
Table 49. GeneScript Corporation Competent Cells Product Offerings
Table 50. GeneScript Corporation Competent Cells Revenue (US$, Mn), (2016-2021)
Table 51. Yeastern Biotech Corporate Summary
Table 52. Yeastern Biotech Competent Cells Product Offerings
Table 53. Yeastern Biotech Competent Cells Revenue (US$, Mn), (2016-2021)
Table 54. New England Biolabs Corporate Summary
Table 55. New England Biolabs Competent Cells Product Offerings
Table 56. New England Biolabs Competent Cells Revenue (US$, Mn), (2016-2021)
Table 57. QIAGEN N.V. Corporate Summary
Table 58. QIAGEN N.V. Competent Cells Product Offerings
Table 59. QIAGEN N.V. Competent Cells Revenue (US$, Mn), (2016-2021)
Table 60. OriGene Technologies Corporate Summary
Table 61. OriGene Technologies Competent Cells Product Offerings
Table 62. OriGene Technologies Competent Cells Revenue (US$, Mn), (2016-2021)
Table 63. Lucigen Corporate Summary
Table 64. Lucigen Competent Cells Product Offerings
Table 65. Lucigen Competent Cells Revenue (US$, Mn), (2016-2021)
Table 66. Zymo Research Corporate Summary
Table 67. Zymo Research Competent Cells Product Offerings
Table 68. Zymo Research Competent Cells Revenue (US$, Mn), (2016-2021)
Table 69. Bio-Rad Laboratories Corporate Summary
Table 70. Bio-Rad Laboratories Competent Cells Product Offerings
Table 71. Bio-Rad Laboratories Competent Cells Revenue (US$, Mn), (2016-2021)
Table 72. Bioline Corporate Summary
Table 73. Bioline Competent Cells Product Offerings
Table 74. Bioline Competent Cells Revenue (US$, Mn), (2016-2021)
Table 75. Delphi Genetics Corporate Summary
Table 76. Delphi Genetics Competent Cells Product Offerings
Table 77. Delphi Genetics Competent Cells Revenue (US$, Mn), (2016-2021)
Table 78. IBA GmBH Corporate Summary
Table 79. IBA GmBH Competent Cells Product Offerings
Table 80. IBA GmBH Competent Cells Revenue (US$, Mn), (2016-2021)
Table 81. Cell Applications Corporate Summary
Table 82. Cell Applications Competent Cells Product Offerings
Table 83. Cell Applications Competent Cells Revenue (US$, Mn), (2016-2021)
Table 84. BioDynamics Laboratory Corporate Summary
Table 85. BioDynamics Laboratory Competent Cells Product Offerings
Table 86. BioDynamics Laboratory Competent Cells Revenue (US$, Mn), (2016-2021)
Table 87. Scarab Genomics Corporate Summary
Table 88. Scarab Genomics Competent Cells Product Offerings
Table 89. Scarab Genomics Competent Cells Revenue (US$, Mn), (2016-2021)
Table 90. GCC Biotech Corporate Summary
Table 91. GCC Biotech Competent Cells Product Offerings
Table 92. GCC Biotech Competent Cells Revenue (US$, Mn), (2016-2021)
Table 93. SMOBIO Technology Corporate Summary
Table 94. SMOBIO Technology Competent Cells Product Offerings
Table 95. SMOBIO Technology Competent Cells Revenue (US$, Mn), (2016-2021)
Table 96. Edge BioSystems Corporate Summary
Table 97. Edge BioSystems Competent Cells Product Offerings
Table 98. Edge BioSystems Competent Cells Revenue (US$, Mn), (2016-2021)
LIST OF FIGURES
Figure 1. Competent Cells Segment by Type
Figure 2. Competent Cells Segment by Application
Figure 3. Global Competent Cells Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Competent Cells Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Competent Cells Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Competent Cells Revenue in 2020
Figure 8. By Type - Global Competent Cells Revenue Market Share, 2016-2027
Figure 9. By Application - Global Competent Cells Revenue Market Share, 2016-2027
Figure 10. By Region - Global Competent Cells Revenue Market Share, 2016-2027
Figure 11. By Country - North America Competent Cells Revenue Market Share, 2016-2027
Figure 12. US Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Competent Cells Revenue Market Share, 2016-2027
Figure 16. Germany Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 17. France Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Competent Cells Revenue Market Share, 2016-2027
Figure 24. China Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 28. India Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Competent Cells Revenue Market Share, 2016-2027
Figure 30. Brazil Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Competent Cells Revenue Market Share, 2016-2027
Figure 33. Turkey Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 37. Merck KGaA Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Thermo Fisher Scientific Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Agilent Technologies Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Takara Bio Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Promega Corporation Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Beijing TransGen Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. GeneScript Corporation Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Yeastern Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. New England Biolabs Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. QIAGEN N.V. Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. OriGene Technologies Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Lucigen Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Zymo Research Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Bio-Rad Laboratories Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Bioline Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Delphi Genetics Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. IBA GmBH Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Cell Applications Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. BioDynamics Laboratory Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Scarab Genomics Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. GCC Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. SMOBIO Technology Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 1. Competent Cells Segment by Type
Figure 2. Competent Cells Segment by Application
Figure 3. Global Competent Cells Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Competent Cells Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Competent Cells Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Competent Cells Revenue in 2020
Figure 8. By Type - Global Competent Cells Revenue Market Share, 2016-2027
Figure 9. By Application - Global Competent Cells Revenue Market Share, 2016-2027
Figure 10. By Region - Global Competent Cells Revenue Market Share, 2016-2027
Figure 11. By Country - North America Competent Cells Revenue Market Share, 2016-2027
Figure 12. US Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Competent Cells Revenue Market Share, 2016-2027
Figure 16. Germany Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 17. France Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Competent Cells Revenue Market Share, 2016-2027
Figure 24. China Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 28. India Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Competent Cells Revenue Market Share, 2016-2027
Figure 30. Brazil Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Competent Cells Revenue Market Share, 2016-2027
Figure 33. Turkey Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Competent Cells Revenue, (US$, Mn), 2016-2027
Figure 37. Merck KGaA Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Thermo Fisher Scientific Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Agilent Technologies Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Takara Bio Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Promega Corporation Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Beijing TransGen Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. GeneScript Corporation Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Yeastern Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. New England Biolabs Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. QIAGEN N.V. Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. OriGene Technologies Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Lucigen Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Zymo Research Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Bio-Rad Laboratories Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Bioline Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Delphi Genetics Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. IBA GmBH Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Cell Applications Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. BioDynamics Laboratory Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Scarab Genomics Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. GCC Biotech Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. SMOBIO Technology Competent Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)